Cutler Group’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,500
| Closed | -$13K | – | 3957 |
|
|
2023
Q4 | $13K | Buy |
+4,500
| New | +$89.6K | ﹤0.01% | 2268 |
|
|
2023
Q2 | – | Sell |
-1,000
| Closed | -$1K | – | 4363 |
|
|
2023
Q1 | $1K | Sell |
1,000
-40,800
| -98% | -$174K | ﹤0.01% | 3647 |
|
|
2022
Q4 | $12K | Sell |
41,800
-8,800
| -17% | -$47.7K | ﹤0.01% | 2603 |
|
|
2022
Q3 | $55K | Hold |
50,600
| – | – | ﹤0.01% | 1828 |
|
|
2022
Q2 | $75K | Buy |
50,600
+24,100
| +91% | +$105K | 0.01% | 1640 |
|
|
2022
Q1 | $43K | Buy |
26,500
+23,100
| +679% | +$128K | ﹤0.01% | 2394 |
|
|
2021
Q4 | $1K | Buy |
+3,400
| New | +$21.1K | ﹤0.01% | 5233 |
|
|
2019
Q2 | – | Sell |
-10,400
| Closed | -$13K | – | 4945 |
|
|
2019
Q1 | $13K | Buy |
+10,400
| New | +$45K | ﹤0.01% | 2349 |
|
|
2018
Q2 | – | Sell |
-12,100
| Closed | -$5K | – | 5077 |
|
|
2018
Q1 | $5K | Buy |
+12,100
| New | +$120K | ﹤0.01% | 3338 |
|
|
2017
Q4 | – | Sell |
-8,600
| Closed | -$1K | – | 6182 |
|
|
2017
Q3 | $1K | Sell |
8,600
-7,200
| -46% | -$47.8K | ﹤0.01% | 5613 |
|
|
2017
Q2 | $4K | Buy |
+15,800
| New | +$72.3K | ﹤0.01% | 5118 |
|
|
2017
Q1 | – | Sell |
-6,900
| Closed | -$6K | – | 7426 |
|
|
2016
Q4 | $6K | Sell |
6,900
-4,100
| -37% | -$8.23K | ﹤0.01% | 4808 |
|
|
2016
Q3 | $14K | Sell |
11,000
-700
| -6% | -$2.04K | ﹤0.01% | 3834 |
|
|
2016
Q2 | $17K | Buy |
11,700
+10,800
| +1,200% | +$67.7K | ﹤0.01% | 3555 |
|
|
2016
Q1 | $2K | Buy |
+900
| New | +$7.61K | ﹤0.01% | 5715 |
|
Other funds holding IMGN
Cutler Group's IMGN Position: Q1 2024 in Review
Cutler Group sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 3,900 shares — an estimated $115K sold.
Cutler Group first reported a position in IMGN in Q1 2016 and held it in 19 quarters. The position peaked at $136K in Q4 2022. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Cutler Group reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Cutler Group sold 3,900 Immunogen Inc shares in Q1 2024, an estimated $115K.
- Cutler Group first reported a position in Immunogen Inc in Q1 2016 and held it in 19 quarters.
- Cutler Group's Immunogen Inc position peaked at $136K in Q4 2022.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.